×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
INDP – indaptus therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
INDP
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/13
07:30 am
indp
Indaptus Therapeutics Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Corporate Update
Low
Report
Indaptus Therapeutics Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Corporate Update
3/12
04:40 pm
indp
Registration Is Now Open For Tribe Public's Webinar Event “Keys To The Kingdom: Unlocking The Power Of Your Immune System” Featuring Indaptus Therapeutics' CEO On Monday, March 17, 2025 [Yahoo! Finance]
Medium
Report
Registration Is Now Open For Tribe Public's Webinar Event “Keys To The Kingdom: Unlocking The Power Of Your Immune System” Featuring Indaptus Therapeutics' CEO On Monday, March 17, 2025 [Yahoo! Finance]
3/12
04:15 pm
indp
Registration Is Now Open For Tribe Public’s Webinar Event “Keys To The Kingdom: Unlocking The Power Of Your Immune System” Featuring Indaptus Therapeutics’ CEO On Monday, March 17, 2025
Medium
Report
Registration Is Now Open For Tribe Public’s Webinar Event “Keys To The Kingdom: Unlocking The Power Of Your Immune System” Featuring Indaptus Therapeutics’ CEO On Monday, March 17, 2025
3/4
08:00 am
indp
Indaptus Therapeutics Expands Patent Portfolio in China, Japan, and Israel, Strengthening its Intellectual Property for Infectious Disease and Cancer Treatments
Medium
Report
Indaptus Therapeutics Expands Patent Portfolio in China, Japan, and Israel, Strengthening its Intellectual Property for Infectious Disease and Cancer Treatments
2/25
08:00 am
indp
Indaptus Therapeutics’ Chief Scientific Officer Dr. Michael Newman to Present at the 10th Annual Innate Killer Summit
Low
Report
Indaptus Therapeutics’ Chief Scientific Officer Dr. Michael Newman to Present at the 10th Annual Innate Killer Summit
2/5
06:17 pm
indp
Indaptus Therapeutics Receives Approval from Health Canada to Expand Clinical Trial of Decoy20 [Yahoo! Finance]
Medium
Report
Indaptus Therapeutics Receives Approval from Health Canada to Expand Clinical Trial of Decoy20 [Yahoo! Finance]
2/5
08:00 am
indp
Indaptus Therapeutics Receives Approval from Health Canada to Expand Clinical Trial of Decoy20
High
Report
Indaptus Therapeutics Receives Approval from Health Canada to Expand Clinical Trial of Decoy20
1/13
08:00 am
indp
Indaptus Therapeutics, Inc. Announces $2.25 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Low
Report
Indaptus Therapeutics, Inc. Announces $2.25 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/13
07:40 am
indp
Form 8-K Indaptus Therapeutics, For: Mar 13
Low
Report
Form 8-K Indaptus Therapeutics, For: Mar 13
3/13
07:35 am
indp
Form POS AM Indaptus Therapeutics,
Low
Report
Form POS AM Indaptus Therapeutics,
3/13
07:31 am
indp
Form 10-K Indaptus Therapeutics, For: Dec 31
Low
Report
Form 10-K Indaptus Therapeutics, For: Dec 31
2/18
04:03 pm
indp
Form SCHEDULE 13G Indaptus Therapeutics, Filed by: YA II PN, Ltd.
Medium
Report
Form SCHEDULE 13G Indaptus Therapeutics, Filed by: YA II PN, Ltd.
2/14
06:05 am
indp
Form EFFECT Indaptus Therapeutics,
Low
Report
Form EFFECT Indaptus Therapeutics,
2/12
11:39 am
indp
Form S-1 Indaptus Therapeutics,
Medium
Report
Form S-1 Indaptus Therapeutics,
2/12
09:22 am
indp
Form 8-K Indaptus Therapeutics, For: Feb 12
High
Report
Form 8-K Indaptus Therapeutics, For: Feb 12
2/12
06:02 am
indp
Form EFFECT Indaptus Therapeutics,
Medium
Report
Form EFFECT Indaptus Therapeutics,
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: